Bajaj Healthcare — 360° view

Bajaj Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹176 crore and net profit of ₹14 crore for the September 2026 quarter.

Bajaj Healthcare (NSE: BAJAJHCARE) closed at ₹320.15 on 20 Nov 2026, down 25.7% over the past year. Its market capitalisation is ₹1,078 crore and it trades at 18.5 times earnings.

Share price
₹320.15 (20 Nov 2026)
Market cap
₹1,078 Cr (20 Nov 2026)
P/E
18.52 (20 Nov 2026)
Revenue
₹176 Cr (September 2026 quarter)
Net profit
₹14 Cr (September 2026 quarter)
ROCE
11.5% (FY26)
ROE
8.26% (FY26)
Book value
₹166 (FY26)
Dividend yield
0.47% (last 12 months to 20 Nov 2026)
52-week high / low
₹458.00 / ₹272.35 (20 Nov 2026)
1-year return
-25.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: BAJAJHCARE

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.